<DOC>
	<DOC>NCT01929070</DOC>
	<brief_summary>The purpose of this study is to evaluate the pharmacokinetics of omega-3 between rosuvastatin and omega-3 coadministration and HCP1007 in healthy male volunteers.</brief_summary>
	<brief_title>A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Adult male aged 20 to 55 years A body mass index between 19 and 27 kg/m2 History of hepatobiliary, renal, gastrointestinal, respiratory, musculoskeletal, endocrinal, hematooncologic or cardiovascular disease SBP &lt; 90 or ≥ 150 mmHg, DBP &lt; 60 or ≥90 mmHg Use of herbal medicine within 30 days, prescriptive medicine within 14 days, or overthecounter drug within 7 days Heavy alcohol consumption (140 g/day)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HCP1007</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Omega-3</keyword>
</DOC>